The current CLCS market cap is 7.71k. The company's latest EPS is USD -0.1641 and P/E is 0.00.
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.01M | -3.81M | -3.64M | -4.02M | -4.18M |
Net Income | -2.57M | -5.22M | -5.44M | -6.45M | -6.33M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 66k | 115k | 452k | 314k | 410k |
Total Liabilities | 4.99M | 5.86M | 8.4M | 10.14M | 13.04M |
Total Equity | -4.92M | -5.74M | -7.95M | -9.83M | -12.63M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -2M | -2.59M | -2.78M | -3.38M | -3.14M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 1.65M | 2.6M | 2.99M | 3.23M | 3.27M |
Market Cap | 7.71k |
Price to Earnings Ratio | 0.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 38.55M |
Average Volume (1 week) | 1.55k |
Average Volume (1 Month) | 6.39k |
52 Week Change | -33.33% |
52 Week High | 0.74 |
52 Week Low | 0.0002 |
Spread (Intraday) | 0 (0%) |
Company Name | Cell Source Inc (CE) |
Address |
701 s carson street carson city, nevada 89701 |
Website | https:// |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.